We are live on ! Find out more
DMK

DMK Pharmaceuticals Corporation Common Stock
DMK

Delisted

DMK was delisted on the 6th of February, 2024.

Back to rankings

49 hedge funds and large institutions have $8.58M invested in DMK Pharmaceuticals Corporation Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

814% more call options, than puts

Call options by funds: $914K | Put options by funds: $100K

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

6% less funds holding

Funds holding: 52 → 49 (-3)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

41% less capital invested

Capital invested by funds: $14.6M → $8.58M (-$6.03M)

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
6
Closed
9
Calls
$914K
Puts
$100K
Net Calls
+$814K
Net Calls Change
-$1M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$294K
2
JP Morgan Chase
JP Morgan Chase
New York
+$171K
3
UBS Group
UBS Group
Switzerland
+$85K
4
Morgan Stanley
Morgan Stanley
New York
+$28.7K
5
Jane Street
Jane Street
New York
+$27.3K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$801K
2
Millennium Management
Millennium Management
New York
-$373K
3
GC
Greenlight Capital
New York
-$283K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$36.2K
5
PCM
Prelude Capital Management
New York
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
BRWA
26
B. Riley Wealth Advisors
Florida
$16K – – –
GSIS
27
Global Strategic Investment Solutions
Arizona
$14K – – –
TSS
28
Two Sigma Securities
New York
$14K +$20.4K +327 New
Victory Capital Management
29
Victory Capital Management
Texas
$13K -$561 -9 -3%
SCA
30
Stonebridge Capital Advisors
Minnesota
$13K – – –
Creative Planning
31
Creative Planning
Kansas
$13K +$19.6K +314 New
Goldman Sachs
32
Goldman Sachs
New York
$12K +$17.5K +281 New
HF
33
HRT Financial
New York
$12K +$19K +305 New
Principal Financial Group
34
Principal Financial Group
Iowa
$11K -$8.92K -143 -36%
FCMT
35
Founders Capital Management (Texas)
Texas
$11K – – –
RW
36
RVW Wealth
California
$11K – – –
Wolverine Trading
37
Wolverine Trading
Illinois
$9K +$13K +209 New
ACA
38
Affinity Capital Advisors
California
$8K – – –
Squarepoint
39
Squarepoint
New York
$8K +$374 +6 +3%
Osaic Holdings
40
Osaic Holdings
Arizona
$8K +$873 +14 +8%
OC
41
Oppenheimer & Co
New York
$7K – – –
MOS
42
MGO One Seven
Ohio
$6K – – –
WWM
43
Wolff Wiese Magana
California
$6K – – –
Cetera Investment Advisers
44
Cetera Investment Advisers
Illinois
$6K +$9.11K +146 New
TF
45
TimeScale Financial
Massachusetts
$3K – – –
AF
46
Allworth Financial
California
$2K – – –
S
47
SignatureFD
Georgia
$1K – – –
Wells Fargo
48
Wells Fargo
California
$1K – – –
GC
49
Greenlight Capital
New York
– -$283K -4,177 Closed
PCM
50
Prelude Capital Management
New York
– -$28K -407 Closed
1
2
3

DMK Hedge Fund Activity: Q4 2021 in Review

49 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q4 2021, worth a combined $8.58M — down 41% from $14.6M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of DMK and 6 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 14 added.

The largest buyer was Citadel Advisors, adding an estimated $294K. The largest seller was Susquehanna International Group, cutting an estimated $801K.

  • 49 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q4 2021, down from 52 in Q3 2021.
  • Funds reported $8.58M of DMK Pharmaceuticals Corporation Common Stock stock for Q4 2021, down 41% quarter-over-quarter.
  • 6 funds opened new DMK Pharmaceuticals Corporation Common Stock positions in Q4 2021 and 9 closed out, a net change of -3 holders.
  • The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q4 2021 was Citadel Advisors, an estimated $294K added.
  • The largest DMK Pharmaceuticals Corporation Common Stock seller in Q4 2021 was Susquehanna International Group, an estimated $801K sold.

Based on aggregated 13F filings for Q4 2021.